Check out our many sample applications and summary statements. Below the list of applications, you’ll also find NIAID and NIH example forms, sharing plans, letters, emails, and more.

Table of Contents

• R01 Sample Applications and Summary Statements
• R03 Sample Applications and Summary Statements
• R15 Sample Applications and Summary Statements
• R21 Sample Applications and Summary Statements
• R21/R33 Sample Application and Summary Statement
• R41, R42, R43, and R44 – Small Business Sample Applications
• F31 – Diversity Sample Applications and Summary Statements
• NIAID and NIH Sample Forms, Plans, Letters, Emails, and More

Sample Applications

Several investigators have graciously agreed to let us post their exceptional applications online.

We are truly indebted to the investigators listed below, who have enabled us to deliver this widely anticipated resource to the research community.

We selected these applications as sound examples of good grantsmanship. That said, time has passed since these grantees applied, and so the samples may not reflect the latest application format or rules. Therefore, always follow your funding opportunity's instructions for application format. We post new samples periodically.

Note: The text of these applications is copyrighted. You may use it only for nonprofit educational purposes provided the document remains unchanged and the PI, the grantee organization, and NIAID are credited.

R01 Sample Applications and Summary Statements

PI and Grantee Institution	Application Resources
William Faubion, Ph.D., of the Mayo Clinic Rochester “Inflammatory cascades disrupt Treg function through epigenetic mechanisms”	Summary Statement Full Application
Chengwen Li, Ph.D., and Richard Samulski, Ph.D., of University of North Carolina at Chapel Hill “Enhance AAV Liver Transduction with Capsid Immune Evasion”	Summary Statement Full Application
Mengxi Jiang, Ph.D., of University of Alabama at Birmingham “Intersection of polyomavirus infection and host cellular responses”	Summary Statement Full Application

 R03 Sample Applications and Summary Statements

The small grant (R03) supports new research projects that can be carried out in a short period of time with limited resources. They are awarded for up to two years and are not renewable. R03s are not intended for new investigators.

PI and Grantee Institution	Application Resources
Martin Karplus, Ph.D., of Harvard University "Modeling atomic structure of the EmrE multidrug pump to design inhibitor peptides"	Full Application
Chad A. Rappleye, Ph.D., of Ohio State University "Forward genetics-based discovery of Histoplasma virulence genes"	Summary Statement Full Application

R15 Sample Applications and Summary Statements

The Academic Research Enhancement Award (R15) program supports small-scale research projects to expose students to research and strengthen the research environment at educational institutions that have not been major recipients of NIH support. They are awarded for up to three years

PI and Grantee Institution	Application Resources
Mohammad Ayoub Mir of Western University of Health Sciences Department "Preferential translation of host cell factors by hantavirus nucleocapsid protein"	Summary Statement Full Application
Rahul Raghavan of Portland State University "Elucidating the evolution of Coxiella to uncover critical metabolic pathways"	Summary Statement Full Application

R21 Sample Applications and Summary Statements

Please note that the R21 funds novel scientific ideas, model systems, tools, agents, targets, and technologies that have the potential to substantially advance biomedical research. R21s are not intended for new investigators, and there is no evidence that they provide a path to an independent research career.

PI and Grantee Institution	Application Resources
Steven W. Dow, DVM, Ph.D., of Colorado State University, Fort Collins "Mechanisms of enteric Burkholderia psuedomallei infection"	Summary Statement Full Application
Joseph M. McCune, MD, Ph.D., of the University of California, San Francisco "Human immune system layering and the neonatal response to vaccines"	Summary Statement Full Application
Peter John Myler, Ph.D., and Marilyn Parsons, Ph.D., of the Seattle Biomedical Research Institute "Ribosome profiling of Trypanosoma brucei"	Summary Statement Full Application
Howard T. Petrie, of Scripps Florida "Lymphoid signals for stromal growth and organization in the thymus."	Summary Statement Full Application
Michael N. Starnbach, Ph.D., of Harvard University Medical School "Alteration of host protein stability by Legionella"	Summary Statement Full Application

 R21/R33 Sample Application and Summary Statement

The R21/R33 supports a two-phased award without a break in funding. It begins with the R21 phase for milestone-driven exploratory or feasibility studies with a possible transition to the R33 phase for expanded development. Transition to the second phase depends on several factors, including the achievement of negotiated milestones.

PI and Grantee Institution	Application Resources
Stephen Dewhurst, Ph.D., of the University of Rochester "The semen enhancer of HIV infection as a novel microbicide target"	Summary Statement Full Application

 R41, R42, R43, and R44 – Small Business Sample Applications

The SBIR (R43/R44) and STTR (R41/R42) programs support domestic small businesses to engage in research and development with the potential for commercialization. Read more about Small Business Programs.

PI and Grantee Institution	Application Resources
Raymond Houghton, InBios International, and David AuCoin, University of Nevada School of Medicine "Antigen Detection assay for the Diagnosis of Melioidosis" (STTR Phase II / R42)	Full Application
Mark Poritz* of BioFire Diagnostics, LLC. "Rapid, automated, detection of viral and bacterial pathogens causing meningitis" (SBIR Phase I / R43)	Full Application
Timothy C. Fong of Cellerant Therapeutics, Inc. "Novel indication for myeloid progenitor use: Induction of tolerance" (STTR Phase I / R41)	Full Application
Jose M. Galarza of Technovax, Inc. "Broadly protective (universal) virus-like particle (VLP) based influenza vaccine" (SBIR Phase I / R43)	Full Application
Patricia Garrett of Immunetics, Inc. "Rapid Test for Recent HIV Infection" (SBIR Phase II / R44)	Full Application
Michael J. Lochhead of MBio Diagnostics, Inc. "Point-of-Care HIV Antigen/Antibody Diagnostic Device" (SBIR Phase II / R44)	Full Application
Kenneth Coleman of Arietis Corporation "Antibiotics for Recalcitrant Infection" (SBIR Fast-Track)	Full Application

*Dr. Mark Poritz submitted the original grant application.  In the course of the first year of funding, Dr. Andrew Hemmert took on increasing responsibility for the work.  For the grant renewal, Dr. Poritz proposed that Dr. Hemmert replace him as the PI.

 F31 – Diversity Sample Applications and Summary Statements

The F31-Diversity supports predoctoral students from underrepresented racial and ethnic groups, those with disabilities, and those from disadvantaged backgrounds. It also provides individualized, mentored research training from outstanding faculty sponsors.

PI and Grantee Institution	Application Resources
Adjoa R. Smalls-Mantey of Columbia University Health Sciences "Characterization of Antibody-Dependent Cellular Cytotoxicity in HIV Infection"	Summary Statement and Full Application
Juan Calix of University of Alabama at Birmingham "The role of wcjE disruption in pneumococcal serotype 11A humoral escape"	Summary Statement and Full Application

 NIAID and NIH Sample Forms, Plans, Letters, Emails, and More

NIAID

• Sample Data Sharing Plan
• Sample Model Organism Sharing Plans
  • Complex Model Organisms Sharing Plan
  • Model Organisms Sharing Plan for Mice
  • Simple Model Organisms Sharing Plan
• Sample Letter to Document Training in the Protection of Human Subjects
• Withdrawal of an Application Sample Form Letter
• Just-in-Time
  • Sample Just-in-Time Email From NIH
  • Just-in-Time Email From NIAID Grants Management
• International Grants
  
  • Preparing for a Foreign Organization System (FOS) Review
  • Subaward Agreement Forms from the Federal Demonstration Partnership
• DMID Quality Management Guidance and Tools

NIH

• Annotated SF 424 Grant Application Forms
• Examples of Project Leadership Plans for Multiple PI Grant Applications
• Example calculations in the Usage of Person Months questions and answers
• SF 424 Application Guide's Additional Format Pages
  • Biosketch Format Pages, Instructions and Samples
  • Fellowship Application Biographical Sketch Sample
  • Predoctoral Fellowship Application Biographical Sketch Sample
  • Postdoctoral Fellowship Application Biographical Sketch Sample
  • Sample Data Tables for Training Grant Applications
• OLAW's Sample Documents for animal research assurances and reports
  • Worksheet for Review of the Vertebrate Animal Section (VAS)